We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

34 hedge funds and large institutions have $6.64M invested in Vaxart in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

8% more capital invested

Capital invested by funds: $6.17M → $6.64M (+$467K)

6% more funds holding

Funds holding: 32 → 34 (+2)

0.11% more ownership

Funds ownership: 2.17% → 2.28% (+0.11%)

Holders
34
Holders Change
+2
Holders Change %
+6.25%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$158K
2
Renaissance Technologies
Renaissance Technologies
New York
+$83.7K
3
WT
Wellcome Trust
United Kingdom
+$78.8K
4
OMC
Oasis Management Company
Cayman Islands
+$66.6K
5
VF
Virtu Financial
New York
+$57.6K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$33K
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.3K
3
UBS Group
UBS Group
Switzerland
-$10.7K
4
Morgan Stanley
Morgan Stanley
New York
-$170
Name Holding Trade Value Shares
Change 		Change in
Stake
KAM
1
Krensavage Asset Management
New York
$1.94M – – –
AC
2
Armistice Capital
New York
$944K +$158K +23,240 +23%
Renaissance Technologies
3
Renaissance Technologies
New York
$818K +$83.7K +12,308 +13%
Vanguard Group
4
Vanguard Group
Pennsylvania
$689K +$4.85K +713 +0.8%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$672K -$15.3K -2,242 -2%
BlackRock
6
BlackRock
New York
$333K +$1.24K +182 +0.4%
GCIA
7
Gabelli & Co Investment Advisers
New York
$154K – – –
BCM
8
Bridgeway Capital Management
Texas
$140K – – –
TL
9
TowerView LLC
New York
$120K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$114K – – –
CCM
11
Carlson Capital Management
Minnesota
$107K – – –
Deutsche Bank
12
Deutsche Bank
Germany
$100K +$3.78K +556 +4%
WT
13
Wellcome Trust
United Kingdom
$87K +$78.8K +11,579 New
OMC
14
Oasis Management Company
Cayman Islands
$74K +$66.6K +9,785 New
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$68K – – –
VF
16
Virtu Financial
New York
$64K +$57.6K +8,462 New
GF
17
Gabelli Funds
New York
$43K – – –
Northern Trust
18
Northern Trust
Illinois
$42K – – –
PNC Financial Services Group
19
PNC Financial Services Group
Pennsylvania
$24K – – –
State Street
20
State Street
Massachusetts
$17K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$16K +$14.7K +2,159 New
RE
22
RBC Europe
United Kingdom
$14.2K +$12.8K +1,887 New
GC
23
Guggenheim Capital
Illinois
$14K +$20 +3 +0.2%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$10K – – –
WS
25
Wedbush Securities
California
$10K – – –
1
2

VXRT Hedge Fund Activity: Q3 2017 in Review

34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2017, worth a combined $6.64M — up 7.6% from $6.17M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VXRT positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, adding an estimated $158K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $33K sold.

  • 34 institutional investors held Vaxart (VXRT) as of Q3 2017, up from 32 in Q2 2017.
  • Funds reported $6.64M of Vaxart stock for Q3 2017, up 7.6% quarter-over-quarter.
  • 6 funds opened new Vaxart positions in Q3 2017 and 3 closed out, a net change of +3 holders.
  • The largest Vaxart buyer in Q3 2017 was Armistice Capital, an estimated $158K added.
  • The largest Vaxart seller in Q3 2017 was Tower Research Capital (TRC), an estimated $33K sold.

Based on aggregated 13F filings for Q3 2017.